SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Patent Owner

Compare Create Portfolio
2Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 41204
 
 
 
C07K PEPTIDES 2190
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 17140
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 13162
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 12103
 
 
 
C07D HETEROCYCLIC COMPOUNDS 11136
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1063
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 696
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 485
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 3113

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0051,138 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASESMar 14, 13Feb 19, 15[C07K]
2015/0025,064 NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOFAug 29, 12Jan 22, 15[C07D, A61K]
2015/0011,551 SULFONAMIDE COMPOUNDS AND USES AS TNAP INHIBITORSFeb 21, 13Jan 08, 15[C07D]
2014/0335,590 METHODS FOR PROMOTING CELL REPROGRAMMINGApr 18, 14Nov 13, 14[C12N]
2014/0256,753 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONSAug 10, 12Sep 11, 14[C07D]
2014/0243,387 METHODS FOR IMPROVING CARDIAC CONTRACTILITYDec 17, 13Aug 28, 14[C12N, G01N]
2014/0235,582 HIV REPLICATION INHIBITORSAug 27, 12Aug 21, 14[C07D, A61K]
2014/0220,106 LYMPHATIC ZIP CODES IN TUMORS AND PRE-MALIGNANT LESIONSSep 13, 13Aug 07, 14[G01N, C07K]
2014/0221,612 Peptides that Selectively Home to Heart Vasculature and Related Conjugates and MethodsNov 27, 13Aug 07, 14[A61K]
2014/0134,231 MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMAMar 15, 13May 15, 14[C12N, C12Q, A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,951,971 Lymphatic zip codes in tumors and pre-malignant lesionsSep 13, 13Feb 10, 15[A61P, G01N, A61K, B82Y, C07K]
8,937,193 Apogossypolone derivatives as anticancer agentsOct 07, 10Jan 20, 15[C07C]
8,912,136 Methods and compositions related to clot-binding compoundsDec 20, 10Dec 16, 14[A61K, C07K]
8,815,804 Methods and compositions related to targeting tumors and woundsFeb 05, 07Aug 26, 14[A61K, C07K]
8,785,499 Targeting NAD biosynthesis in bacterial pathogensJul 12, 10Jul 22, 14[A61K]
8,753,604 Methods and compositions for synaphically-targeted treatment for cancerDec 23, 09Jun 17, 14[A61K]
8,748,632 Positive allosteric modulators of group II mGluRsMar 18, 11Jun 10, 14[C07D, A61K]
8,686,003 Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcificationDec 07, 11Apr 01, 14[A61K]
8,642,283 Screening assay for agents that alter target of rapamycin activityMay 26, 06Feb 04, 14[C12Q, G01N]
8,637,635 Peptides that selectively home to heart vasculature and related conjugates and methodsJan 29, 09Jan 28, 14[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USESep 28, 11Aug 29, 13[C07K]
2013/0183,241 PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAMEDec 10, 12Jul 18, 13[A61K]
2013/0157,260 IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSISDec 02, 10Jun 20, 13[G01N]
2013/0064,799 METHODS FOR PROMOTING CELL REPROGRAMMINGMay 31, 12Mar 14, 13[C12N, C40B, G01N, A61K]
2013/0058,993 METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDESFeb 28, 12Mar 07, 13[A61P, A61K, B82Y, C07K]
2012/0276,122 METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSOct 31, 11Nov 01, 12[C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0204,273 COMPOSITIONS RELATING TO A PHOSPHOPROTEIN AND METHODS OF USEDec 22, 11Aug 09, 12[C12N, A01K, A61P, C12Q, G01N, A61K]
2012/0196,922 ZNF206: A NOVEL REGULATOR OF EMBRYONIC STEM CELL SELF-RENEWAL AND PLURIPOTENCYDec 05, 11Aug 02, 12[C12N, C07H, C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0190,615 METHODS AND COMPOSITIONS FOR INDUCING WEIGHT LOSSJan 18, 12Jul 26, 12[A61P, A61K]
2012/0094,922 SCREENING ASSAYS FOR AGENTS THAT ALTER INHIBITOR OF APOPTOSIS (IAP) PROTEIN REGULATION OF CASPASE ACTIVITYNov 02, 11Apr 19, 12[A61P, C12Q, G01N, A61K]
2012/0095,032 METHODS FOR TREATING LEUKEMIA AND MYELODYSPLASTIC SYNDROME, AND METHODS FOR IDENTIFYING AGENTS FOR TREATING SAMEDec 06, 11Apr 19, 12[C12N, A61P, A61K]
2012/0095,078 METHODS OF DIAGNOSIS AND TREATMENT OF MELANOMAOct 07, 11Apr 19, 12[C40B, A61P, C12Q, A61K]
2012/0088,678 METHOD FOR PREDICTION OF RESPONSE TO RHEUMATOID ARTHRITIS THERAPEUTICSSep 08, 11Apr 12, 12[C40B, C12Q, G01N]
2012/0088,771 TISSUE-NONSPECIFIC ALKALINE PHOSPHATASE (TNAP): A THERAPEUTIC TARGET FOR ARTERIAL CALCIFICATIONOct 11, 11Apr 12, 12[C07D, A61P, C07C, A61K]
2012/0071,629 APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCERJul 20, 11Mar 22, 12[C07H, C07K]
2012/0046,195 DETECTING BCL-B EXPRESSION IN CANCER AND USES THEREOFOct 31, 11Feb 23, 12[C40B, C12Q, G01N]
2012/0046,329 MODULATORS OF NOD1 AND NOD2 SIGNALING, METHODS OF IDENTIFYING MODULATORS OF NOD1 AND NOD2 SIGNALING, AND USES THEREOFAug 10, 11Feb 23, 12[C12N, C40B, A61P, A61K]
2012/0046,446 p16 MEDIATED REGULATION OF NMDA RECEPTORSAug 12, 11Feb 23, 12[C07H, C07K]
2012/0034,164 TRUNCATED CAR PEPTIDES AND METHODS AND COMPOSITIONS USING TRUNCATED CAR PEPTIDESSep 01, 11Feb 09, 12[A61P, A61K, C07K]
2012/0014,974 METHODS OF MODULATING CELL DEATH BASED ON THE BIT1/AES REGULATORY PATHWAYJun 06, 11Jan 19, 12[A61P, C12Q, A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.